PURPOSE: The aim of this study was to assess whether hyperglycaemia in the post-operative period of total knee arthroplasty (TKA) affects post-operative complications regardless of diabetes mellitus (DM) diagnosis. METHODS: All patients who had undergone primary TKA were included in the study. The following data were recorded: DM diagnosis, and pre- (BGL1), intra- (BGL2) and post-operative blood glucose levels (BGL3). After 1-year follow-up, medical, infectious and mechanical or surgery-related complications were recorded. RESULTS: Of the 833 patients included, 130 (15.6 %) were diabetic. Median BGL1, BGL2 and BGL3 were 106.13, 93.49 and 134.16 mg/dl, respectively. After follow-up, 173 (20.8 %) patients presented complications, including 48 (5.76 %) medical complications and 94 (11.28 %) infections. Surgery-related complications presented in 31 (3.72 %) patients. A statistically significant association was found between BGL3 ≥ 126 mg/dl and complications (OR 1.95, p < 0.001), medical complications (OR 3.98, p < 0.001), and infections (OR 1.76, p < 0.006). CONCLUSIONS: Hyperglycaemia during the post-operative period in diabetic and non-diabetic patients undergoing TKA increases post-operative medical and infectious complications. Glycemic control during this period must be performed in order to reduce these complications. LEVEL OF EVIDENCE: Retrospective case series, Level IV.
PURPOSE: The aim of this study was to assess whether hyperglycaemia in the post-operative period of total knee arthroplasty (TKA) affects post-operative complications regardless of diabetes mellitus (DM) diagnosis. METHODS: All patients who had undergone primary TKA were included in the study. The following data were recorded: DM diagnosis, and pre- (BGL1), intra- (BGL2) and post-operative blood glucose levels (BGL3). After 1-year follow-up, medical, infectious and mechanical or surgery-related complications were recorded. RESULTS: Of the 833 patients included, 130 (15.6 %) were diabetic. Median BGL1, BGL2 and BGL3 were 106.13, 93.49 and 134.16 mg/dl, respectively. After follow-up, 173 (20.8 %) patients presented complications, including 48 (5.76 %) medical complications and 94 (11.28 %) infections. Surgery-related complications presented in 31 (3.72 %) patients. A statistically significant association was found between BGL3 ≥ 126 mg/dl and complications (OR 1.95, p < 0.001), medical complications (OR 3.98, p < 0.001), and infections (OR 1.76, p < 0.006). CONCLUSIONS: Hyperglycaemia during the post-operative period in diabetic and non-diabeticpatients undergoing TKA increases post-operative medical and infectious complications. Glycemic control during this period must be performed in order to reduce these complications. LEVEL OF EVIDENCE: Retrospective case series, Level IV.
Authors: Yinn Cher Ooi; T Forcht Dagi; Mitchell Maltenfort; Fred Rincon; Matthew Vibbert; Pascal Jabbour; L Fernando Gonzalez; Robert Rosenwasser; Jack Jallo Journal: Neurosurgery Date: 2012-09 Impact factor: 4.654
Authors: Richard Iorio; Kelly M Williams; Andrew J Marcantonio; Lawrence M Specht; John F Tilzey; William L Healy Journal: J Arthroplasty Date: 2011-11-04 Impact factor: 4.757
Authors: Gunjan Y Gandhi; M Hassan Murad; David N Flynn; Patricia J Erwin; Alexandre B Cavalcante; Henning Bay Nielsen; Sarah E Capes; Kristian Thorlund; Victor M Montori; P J Devereaux Journal: Mayo Clin Proc Date: 2008-04 Impact factor: 7.616
Authors: Milford H Marchant; Nicholas A Viens; Chad Cook; Thomas Parker Vail; Michael P Bolognesi Journal: J Bone Joint Surg Am Date: 2009-07 Impact factor: 5.284
Authors: Javier Z Guzman; Branko Skovrlj; John Shin; Andrew C Hecht; Sheeraz A Qureshi; James C Iatridis; Samuel K Cho Journal: Spine (Phila Pa 1976) Date: 2014-09-15 Impact factor: 3.468
Authors: Jorge Arias-de la Torre; Kayla Smith; Alexandru Dregan; Jose M Valderas; Jonathan P Evans; Daniel Prieto-Alhambra; Luis Lozano; Antonio J Molina; Vicente Martín; Laia Domingo; Laura Muñoz; Mireia Espallargues Journal: BMC Musculoskelet Disord Date: 2020-07-09 Impact factor: 2.362